These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38727044)
1. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts. Taipale H; Lieslehto J; Lähteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljärvi T; Solmi M; Cipriani A; Correll CU; Tiihonen J World Psychiatry; 2024 Jun; 23(2):276-284. PubMed ID: 38727044 [TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder. Hamina A; Taipale H; Lieslehto J; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J JAMA Netw Open; 2024 Oct; 7(10):e2438358. PubMed ID: 39382894 [TBL] [Abstract][Full Text] [Related]
3. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients. Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348 [TBL] [Abstract][Full Text] [Related]
5. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia. Luykx JJ; Correll CU; Manu P; Tanskanen A; Hasan A; Tiihonen J; Taipale H JAMA Psychiatry; 2024 Oct; 81(10):967-975. PubMed ID: 38922592 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study. Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338 [TBL] [Abstract][Full Text] [Related]
8. Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety. Lintunen J; Hamina A; Lähteenvuo M; Paljärvi T; Tanskanen A; Tiihonen J; Taipale H Acta Psychiatr Scand; 2025 Jan; 151(1):81-91. PubMed ID: 39355920 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis. Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J Am J Psychiatry; 2022 Dec; 179(12):938-946. PubMed ID: 36200276 [TBL] [Abstract][Full Text] [Related]
10. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study. Lähteenvuo M; Paljärvi T; Tanskanen A; Taipale H; Tiihonen J Br J Psychiatry; 2023 Oct; 223(4):456-464. PubMed ID: 37395140 [TBL] [Abstract][Full Text] [Related]
11. Association of Treatment With Antipsychotics, Antidepressants, or Both With Movement Disorders and Seizures Among Children and Adolescents With Depression in Korea. Jeon SM; Park HY; Park S; Chung US; Kwon JW JAMA Netw Open; 2022 Apr; 5(4):e227074. PubMed ID: 35426925 [TBL] [Abstract][Full Text] [Related]
12. Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes. Taipale H; Bergström J; Gèmes K; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M JAMA Netw Open; 2024 Mar; 7(3):e242859. PubMed ID: 38506810 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Denissoff A; Taipale H; Tiihonen J; Di Forti M; Mittendorfer-Rutz E; Tanskanen A; Mustonen A; Niemelä S Schizophr Bull; 2024 Nov; 50(6):1287-1294. PubMed ID: 38534050 [TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Taipale H; Mehtälä J; Tanskanen A; Tiihonen J Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901 [TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
18. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia. Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216 [TBL] [Abstract][Full Text] [Related]
19. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine. Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H Br J Psychiatry; 2020 Sep; 217(3):498-505. PubMed ID: 31910911 [TBL] [Abstract][Full Text] [Related]
20. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies. Xing S; Kim S; Schumock GT; Touchette DR; Calip GS; Leow AD; Lee TA Prim Care Companion CNS Disord; 2018 May; 20(3):. PubMed ID: 29873957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]